Skip to content
Application 211189
- Type
- ANDA
- Sponsor
- GLAND PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TOBRAMYCIN SULFATE | TOBRAMYCIN SULFATE | INJECTABLE;INJECTION | EQ 1.2GM BASE/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 68083-312 | Tobramycin | Tobramycin | Gland Pharma Limited | ANDA | Current |
| 68083-312 | Tobramycin | Tobramycin | Gland Pharma Limited | ANDA | Current |
| 70700-173 | Tobramycin | Tobramycin | Xiromed LLC | ANDA | Current |
| 70700-173 | Tobramycin | Tobramycin | Xiromed LLC | ANDA | Current |
| 70700-173 | Tobramycin | Tobramycin | Xiromed LLC | ANDA | Current |
| 72266-163 | Tobramycin | Tobramycin | Fosun Pharma USA Inc | ANDA | Current |
| 72266-163 | Tobramycin | Tobramycin | Fosun Pharma USA Inc | ANDA | Current |